Search Results - "fibril"

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION by M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov

Connect to this object online.

Thromboprophylaxis in atrial fibrillation: correct interpretation and effective use of CHA2DS2-VASc and HAS-BLED scores by Mateusz Wawrzeńczyk, Maria Kotulska, Aleksandra Suchenia, Agnieszka Dzido, Krzysztof Lachowski

Connect to this object online.

Патогенетические механизмы фибрилляции предсердий и формирования предсердного фиброза = Pathogenic mechanisms of atrial fibrillation and atrial fibrosis formation by A. I. Gozhenko, N. R. Bayazitov, E. M. Levchenko, V. V. Goriachyi, A. V. Goriachyi

Connect to this object online.

How Family Members Experienced a Family-Focused Atrial Fibrillation Intervention in an Outpatient Setting-A Qualitative Study by Stine Rosenstrøm MSc, RN, Wan Xui Chou MScN, RN, Anne Brødsgaard PhD, MPH, RN

Connect to this object online.

Efficacy and Safety of Different Energy Settings for Atrial Fibrillation Ablation using the Duty-cycled Radiofrequency Ablation Catheter (PVAC) by Stefan Lönnerholm, Helena Malmborg, Per Blomström, Carina Blomström-Lundqvist

Connect to this object online.

Updates in Anesthesia The Operating Room and Beyond

Subjects: “…atrial fibrillation…”
DOAB: download the publication
DOAB: description of the publication

Anticoagulant Drugs

Subjects: “…anticoagulants, atrial fibrillation, comorbidity, hemodialysis, heparin, anticoagulation…”
DOAB: download the publication
DOAB: description of the publication

Correction: Jahić Mujkić et al. Synergy of the Inhibitory Action of Polyphenols Plus Vitamin C on Amyloid Fibril Formation: Case Study of Human Stefin B. <i>Antioxidants</i> 2021, <i>10</i>, 1471 by Alma Jahić Mujkić, Magda Tušek Žnidarič, Selma Berbić, Eva Žerovnik

Connect to this object online.

SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP by E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

Predicting Cost‐Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States by Ching‐Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua Brown

Connect to this object online.

Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure by Ma J, Yin C, Ma S, Qiu H, Zheng C, Chen Q, Ding C, Lv W

Connect to this object online.

Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) by I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin

Connect to this object online.

Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms by Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev

Connect to this object online.

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES by M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov

Connect to this object online.

Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention by V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova

Connect to this object online.

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION by O. V. Gaisenok

Connect to this object online.

Arrhythmia Termination During Radiofrequency Delivery Improves Outcomes after Catheter Ablation for Persistent and Long Standing Persistent Atrial Fibrillation by Alexandrina NASTASA, Corneliu IORGULESCU, Stefan BOGDAN, Silvia DEACONU, Stefan PETRE, Viviana GONDOS, Maria DOROBANTU, Radu Gabriel VATASESCU

Connect to this object online.

Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction by Murat Selçuk, Tufan Çınar, Faysal Şaylık, Tayyar Akbulut, Suha Asal, Vedat Çiçek, Mert İlker Hayıroğlu, İbrahim Halil Tanboğa

Connect to this object online.

The Role of Epicardial Adipose Tissue-Derived Proteins in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation: A Bioinformatics Analysis by Huang K, Lu J, Li Q, Wang C, Ding S, Xu X, Han L

Connect to this object online.

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study by Cheima Amrouch, Cheima Amrouch, Davide Liborio Vetrano, Davide Liborio Vetrano, Cecilia Damiano, Lu Dai, Amaia Calderón-Larrañaga, Amaia Calderón-Larrañaga, Maxim Grymonprez, Maxim Grymonprez, Marco Proietti, Marco Proietti, Gregory Y. H. Lip, Gregory Y. H. Lip, Søren P. Johnsen, Jonas W. Wastesson, Jonas W. Wastesson, Kristina Johnell, Delphine De Smedt, Mirko Petrovic

Connect to this object online.